{"id":1916,"date":"2019-09-26T19:49:29","date_gmt":"2019-09-26T17:49:29","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=1916"},"modified":"2024-12-19T13:23:18","modified_gmt":"2024-12-19T12:23:18","slug":"neuro-oncologia","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-cancer\/programa-de-mecanismes-moleculars-i-terapia-experimental-en-oncologia-oncobell\/neuro-oncologia\/","title":{"rendered":"Neurooncologia"},"content":{"rendered":"\n<h1>\n\t\tNeuro-oncologia\n\t<\/h1>\n<h3>\n\t\tResum\n\t<\/h3>\n\t<p>El grup de Neuro-oncologia se centra en l&#8217;estudi dels tractaments de tumors cerebrals i les complicacions neurol\u00f2giques relacionades amb el c\u00e0ncer i els tractaments contra el c\u00e0ncer. L&#8217;objectiu del grup \u00e9s crear i refor\u00e7ar una xarxa de recerca entre investigadors cl\u00ednics i precl\u00ednics tant dins com fora de la instituci\u00f3,\u00a0 per proporcionar noves opcions terap\u00e8utiques per a pacients, millorar les eines de diagn\u00f2stic i contribuir a augmentar els coneixements en aquests camps.<\/p>\n<h2>379<\/h2>\n<h2>Publicacions<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/04\/119-neurooncologia-jbruna-def.jpg\" alt=\"119-neurooncologia-jbruna-def\" itemprop=\"image\" height=\"300\" width=\"600\" title=\"119-neurooncologia-jbruna-def\" onerror=\"this.style.display='none'\"  \/>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-0\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-0\">L\u00ednies estrat\u00e8giques<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-0\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\tAvaluaci\u00f3 de nous f\u00e0rmacs i nous enfocaments de tractament contra gliomes i meningiomes (Jordi Bruna, Carles Mesia, Ana Lucas, Carles Maj\u00f3s, Gerard Plans)<br \/>\nNeuropaties perif\u00e8riques indu\u00efdes per quimioter\u00e0pia (Jordi Bruna, Roser Velasco)<br \/>\nC\u00e0ncer i cognici\u00f3 (Marta Sim\u00f3)<br \/>\nMet\u00e0stasis leptomen\u00edngees (Jordi Bruna)<br \/>\nFactors pron\u00f2stics de superviv\u00e8ncia implicats en els tumors del sistema nervi\u00f3s central (Noem\u00ed Vidal, Jordi Bruna, Carles Maj\u00f3s. Albert Pons, Gerard Plans)<br \/>\nPrevenci\u00f3 i tractament personalitzat de met\u00e0stasis cerebrals: desenvolupament de noves ter\u00e0pies basades en la prevenci\u00f3 i pron\u00f2stic de biomarcadors (Carles Mesia, Noem\u00ed Vidal, Gerard Plans, Ana Lucas)<br \/>\nValoraci\u00f3 quantitativa de t\u00e8cniques avan\u00e7ades de RM en neurooncologia cl\u00ednica (Carles Majos, Albert Pons)\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-1\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-1\">Publicacions seleccionades<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-1\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>Nadal,E;Rodr\u00edguez Abreu,D;Sim\u00f3,M;Massut\u00ed,B;Juan,O;Huidobro,G;L\u00f3pez,R et al, <strong>Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17\/05)<\/strong>, J. Clin. Oncol., 2023;41(28):4478-4485, doi:10.1200\/JCO.22.02561<\/li>\n<li>Velasco,R;Argyriou,AA;Marco,C;Mariotto,S;Stradella,A;Hern\u00e1ndez,J;Pernas,S et al, <strong>Serum neurofilament levels correlate with electrodiagnostic evidence of axonal loss in paclitaxel-induced peripheral neurotoxicity<\/strong>., J. Neurol., 2023;270(1):531-537, doi:10.1007\/s00415-022-11377-4<\/li>\n<li>Maj\u00f3s,C;Pons Escoda,A;Naval,P;Guell,A;Lucas,A;Vidal,N;Cos,M et al, <strong>Proton MR spectroscopy shows improved performance to segregate high-grade astrocytoma subgroups when defined with the new 2021 World Health Organization classification of central nervous system tumors<\/strong>, Eur. Radiol., 2023;doi:10.1007\/s00330-023-10138-9<\/li>\n<li>Alemany,M;Todeschini,FA;Vidal,N;Pons,A;Plans,G;Vilarino,N;Maci\u00e0,M et al, <strong>The impact of health system crises on glioblastoma management and outcomes, Neuro-Oncology<\/strong>, 2023;25(3):609-611, doi:10.1093\/neuonc\/noac266<\/li>\n<li>Pons Escoda,A;Garcia Ruiz,A;Garcia Hidalgo,C;Gil Solsona,R;Naval Baudin,P;Martin Noguerol,T;Fernandez Coello,A et al, <strong>MR dynamic-susceptibility-contrast perfusion metrics in the presurgical discrimination of adult solitary intra-axial cerebellar tumors<\/strong>, Eur. Radiol., 2023;33(12):9120-9129, doi:10.1007\/s00330-023-09892-7,<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-2\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-2\">Projectes seleccionats<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-2\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>FIS21056. <strong>Comprensi\u00f3n y modulaci\u00f3n de los mecanismos de respuesta senescente en la neuropat\u00eda inducida por platinos<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 165.770\u20ac. 2022-2024. PI: Bruna Escuer, Jordi.<\/li>\n<li>21FIS037. <strong>Valoraci\u00f3n pron\u00f3stica de los gliomas cerebrales mediante Espectroscpia por RM (MRS-PROG)<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 58.080\u20ac. 2021-2023. PI: MAJOS TORRO, CARLOS.<\/li>\n<li>19FIS035. <strong>C\u00e1ncer de pulm\u00f3n y toxicidad cognitiva: marcadores serol\u00f3gicos y de neuroimagen de disrupci\u00f3n de la barrera hemato-encef\u00e1lica. Instituto de Salud Carlos III (ISCIII)<\/strong>. Budget: 93.170\u20ac. 2019-2023. PI: Sim\u00f3 Parra, Marta.<\/li>\n<li>21FIS039. <strong>Neurotoxicidad inducida por quimioterapia y estado nutricional: biomarcadores cl\u00ednicos, s\u00e9ricos, radiol\u00f3gicos y neurofisol\u00f3gicos asociados al desarrollo y la regeneraci\u00f3n nerviosa<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 93.170\u20ac. 2021-2024. PI: VELASCO FARGAS, ROSER.<\/li>\n<li>2022-231-1. <strong>Estudio de fase II, multic\u00e9ntrico, aleatorizado, con doble enmascaramiento, de grupos paralelos y controlado con placebo para evaluar la eficacia y la seguridad de ATX01 (Clorhidrato de Amitriptilina t\u00f3pica al 10 % y al 15 % p\/p) en comparaci\u00f3n con placebo en pacientes adultos que han sobrevivido a un c\u00e1ncer y presentan neuropat\u00eda perif\u00e9rica inducida por quimioterapia -NPIQ<\/strong>. WORLDWIDE CLINICAL TRIALS, INC. Budget: 58.375,75\u20ac. 2022- . PI: Bruna Escuer, Jordi.<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-3\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-3\">M\u00e9s informaci\u00f3<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-3\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\tIdentificaci\u00f3 de marcadors de risc predictiu cl\u00ednic i neurofisiol\u00f2gic per desenvolupar neuropatia indu\u00efda per oxaliplat\u00ed<br \/>\nNoves demostracions sobre l&#8217;efic\u00e0cia del nou antagonista del receptor sigma-1 per prevenir la neuropatia aguda de oxaliplat\u00ed en un estudi aleatoritzat de fase 2<br \/>\nDocumentaci\u00f3 dels canvis longitudinals del cervell associats amb la irradiaci\u00f3 cerebral profil\u00e0ctica i la quimioter\u00e0pia en pacients amb c\u00e0ncer de pulm\u00f3 de c\u00e8l\u00b7lules petites<br \/>\nIdentificaci\u00f3 d&#8217;un tret com\u00fa en glioblastomes: la defici\u00e8ncia intr\u00ednseca de la endonucleasa DFF40 \/ CAD que afecta la hidr\u00f2lisi de l&#8217;ADN durant la mort cel\u00b7lular caspasa-dependent\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/10\/Jordi-Bruna22-150x150.jpg\" alt=\"Jordi-Bruna22\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Jordi-Bruna22\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tBruna Escuer, Jordi\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:jbruna@idibell.cat\" title=\"jbruna@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tjbruna@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tInvestigadors principals\n\t<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/10\/Jordi-Bruna22-150x150.jpg\" alt=\"Jordi-Bruna22\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Jordi-Bruna22\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tBruna Escuer, Jordi\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:jbruna@idibell.cat\" title=\"jbruna@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tjbruna@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/02\/Marta-Simo-150x150.jpg\" alt=\"Marta-Simo\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Marta-Simo\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tSimo Parra, Marta\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:msimo@idibell.cat\" title=\"msimo@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tmsimo@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/11\/Roser-Velasco-Fargas-150x150.jpg\" alt=\"Roser-Velasco-Fargas\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Roser-Velasco-Fargas\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tVelasco Fargas, Roser\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:rvelasco@idibell.cat\" title=\"rvelasco@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\trvelasco@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/05\/Carles-Majos-Torro-150x150.jpg\" alt=\"Carles-Majos-Torro\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Carles-Majos-Torro\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tMajos Torro, Carlos\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:cmajos@idibell.cat\" title=\"cmajos@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tcmajos@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\tENLLA\u00c7OS RELACIONATS\n\t<\/h4>\n<h4>\n\t\t<a href=\"https:\/\/twitter.com\/VelascoRoser\" title=\"@VelascoRoser\" target=\"_self\">\n\t\t@VelascoRoser\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tEquip\n\t<\/h2>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-0\" data-index=\"0\" aria-selected=\"true\" aria-controls=\"fl-tabs--panel-0\" aria-expanded=\"true\" role=\"tab\" tabindex=\"0\">\t\t\t\tCaps de grup\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-1\" data-index=\"1\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-1\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tInvestigadors\/es principals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-2\" data-index=\"2\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-2\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tInvestigadors\/es cl\u00ednics\/ques\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-3\" data-index=\"3\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-3\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tInvestigadors\/es predoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-4\" data-index=\"4\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-4\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tSuport de gesti\u00f3\t\t\t\t<\/a>\n\t\t\t\t\t\tCaps de grup\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Bruna Escuer, Jordi<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es principals\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Velasco Fargas, Roser<\/li>\n<li>Simo Parra, Marta<\/li>\n<li>Majos Torro, Carlos<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es cl\u00ednics\/ques\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Mesia Barroso, Carlos<\/li>\n<li>Lucas Calduch, Anna Maria<\/li>\n<li>Fern\u00e1ndez Coello, Alejandro<\/li>\n<li>Vidal Sarro, Noemi<\/li>\n<li>Plans Ahicart, Gerard<\/li>\n<li>Pons Escoda, Albert<\/li>\n<li>Gabarros Canals, Andreu<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es predoctorals\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Alemany\u00a0 Mart\u00ed, Montserrat<\/li>\n<\/ul>\n\t\t\t\t\t\tSuport de gesti\u00f3\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Sala Corominas, Ros\u00f3<\/li>\n<li>Rodriguez Soriano, Sergio<\/li>\n<\/ul>\n<h2>\n\t\tNot\u00edcies relacionades\n\t<\/h2>\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/26295\" content=\"Bellvitge lidera la creaci\u00f3 d'una nova eina m\u00e9s precisa per avaluar la toxicitat neurol\u00f2gica provocada per la quimioter\u00e0pia\" \/><meta itemprop=\"datePublished\" content=\"2024-09-27\" \/><meta itemprop=\"dateModified\" content=\"2024-09-27\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2024\/09\/NO089-Bruna-web.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/09\/bellvitge-lidera-la-creacio-duna-nova-eina-mes-precisa-per-avaluar-la-toxicitat-neurologica-provocada-per-la-quimioterapia\/\" title=\"Bellvitge lidera la creaci\u00f3 d'una nova eina m\u00e9s precisa per avaluar la toxicitat neurol\u00f2gica provocada per la quimioter\u00e0pia\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/09\/bellvitge-lidera-la-creacio-duna-nova-eina-mes-precisa-per-avaluar-la-toxicitat-neurologica-provocada-per-la-quimioterapia\/\" title=\"Bellvitge lidera la creaci\u00f3 d'una nova eina m\u00e9s precisa per avaluar la toxicitat neurol\u00f2gica provocada per la quimioter\u00e0pia\">Bellvitge lidera la creaci\u00f3 d&#8217;una nova eina m\u00e9s precisa per avaluar la toxicitat neurol\u00f2gica provocada per la quimioter\u00e0pia<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t27\/09\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/25210\" content=\"Una nova eina basada en la Intel\u2022lig\u00e8ncia Artificial permetr\u00e0 millorar el diagn\u00f2stic de tumors cerebrals\" \/><meta itemprop=\"datePublished\" content=\"2024-03-12\" \/><meta itemprop=\"dateModified\" content=\"2024-03-12\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2024\/03\/Captura-de-pantalla-2024-03-12-131024.png\" \/><meta itemprop=\"width\" content=\"1363\" \/><meta itemprop=\"height\" content=\"905\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/03\/una-nova-eina-basada-en-la-intelligencia-artificial-permetra-millorar-el-diagnostic-de-tumors-cerebrals\/\" title=\"Una nova eina basada en la Intel\u2022lig\u00e8ncia Artificial permetr\u00e0 millorar el diagn\u00f2stic de tumors cerebrals\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/03\/una-nova-eina-basada-en-la-intelligencia-artificial-permetra-millorar-el-diagnostic-de-tumors-cerebrals\/\" title=\"Una nova eina basada en la Intel\u2022lig\u00e8ncia Artificial permetr\u00e0 millorar el diagn\u00f2stic de tumors cerebrals\">Una nova eina basada en la Intel\u2022lig\u00e8ncia Artificial permetr\u00e0 millorar el diagn\u00f2stic de tumors cerebrals<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t12\/03\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/24106\" content=\"Primer assaig cl\u00ednic d'un tractament que ataca el c\u00e0ncer de pulm\u00f3 i la met\u00e0stasi al cervell a la vegada\" \/><meta itemprop=\"datePublished\" content=\"2023-08-22\" \/><meta itemprop=\"dateModified\" content=\"2023-08-22\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/08\/DSC0853-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1704\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/08\/primer-assaig-clinic-dun-tractament-que-ataca-el-cancer-de-pulmo-i-la-metastasi-al-cervell-a-la-vegada\/\" title=\"Primer assaig cl\u00ednic d'un tractament que ataca el c\u00e0ncer de pulm\u00f3 i la met\u00e0stasi al cervell a la vegada\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/08\/primer-assaig-clinic-dun-tractament-que-ataca-el-cancer-de-pulmo-i-la-metastasi-al-cervell-a-la-vegada\/\" title=\"Primer assaig cl\u00ednic d'un tractament que ataca el c\u00e0ncer de pulm\u00f3 i la met\u00e0stasi al cervell a la vegada\">Primer assaig cl\u00ednic d&#8217;un tractament que ataca el c\u00e0ncer de pulm\u00f3 i la met\u00e0stasi al cervell a la vegada<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t22\/08\/2023\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/24038\" content=\"L'estudi de lesions cerebrals revela connexions neuronals clau en l&#8217;epil\u00e8psia\" \/><meta itemprop=\"datePublished\" content=\"2023-07-21\" \/><meta itemprop=\"dateModified\" content=\"2023-07-21\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/07\/NO069-JAMA-Onco-Bruna_Imatge-noti.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/07\/lestudi-de-lesions-cerebrals-revela-connexions-neuronals-clau-en-lepilepsia\/\" title=\"L'estudi de lesions cerebrals revela connexions neuronals clau en l&#8217;epil\u00e8psia\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/07\/lestudi-de-lesions-cerebrals-revela-connexions-neuronals-clau-en-lepilepsia\/\" title=\"L'estudi de lesions cerebrals revela connexions neuronals clau en l&#8217;epil\u00e8psia\">L&#8217;estudi de lesions cerebrals revela connexions neuronals clau en l&#8217;epil\u00e8psia<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t21\/07\/2023\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/22883\" content=\"El diagn\u00f2stic i tractament del glioblastoma durant la crisi financera del 2008 i la pand\u00e8mia de COVID-19\" \/><meta itemprop=\"datePublished\" content=\"2023-02-17\" \/><meta itemprop=\"dateModified\" content=\"2023-02-17\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/02\/NO016-Bruna_Neuro-oncology.jpg\" \/><meta itemprop=\"width\" content=\"1081\" \/><meta itemprop=\"height\" content=\"681\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/02\/el-diagnostic-i-tractament-del-glioblastoma-durant-la-crisi-financera-del-2008-i-la-pandemia-de-covid-19\/\" title=\"El diagn\u00f2stic i tractament del glioblastoma durant la crisi financera del 2008 i la pand\u00e8mia de COVID-19\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/02\/el-diagnostic-i-tractament-del-glioblastoma-durant-la-crisi-financera-del-2008-i-la-pandemia-de-covid-19\/\" title=\"El diagn\u00f2stic i tractament del glioblastoma durant la crisi financera del 2008 i la pand\u00e8mia de COVID-19\">El diagn\u00f2stic i tractament del glioblastoma durant la crisi financera del 2008 i la pand\u00e8mia de COVID-19<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t17\/02\/2023\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/19893\" content=\"Aconsegueixen activar una prote\u00efna clau per completar el proc\u00e9s de mort per apoptosi en c\u00e8l\u00b7lules de glioblastoma\" \/><meta itemprop=\"datePublished\" content=\"2021-11-24\" \/><meta itemprop=\"dateModified\" content=\"2021-11-24\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/11\/nuclear-fragments-in-gossypol-glioblastoma-treated-cell-1.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/11\/aconsegueixen-activar-una-proteina-clau-per-completar-el-proces-de-mort-per-apoptosi-en-cellules-de-glioblastoma\/\" title=\"Aconsegueixen activar una prote\u00efna clau per completar el proc\u00e9s de mort per apoptosi en c\u00e8l\u00b7lules de glioblastoma\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/11\/aconsegueixen-activar-una-proteina-clau-per-completar-el-proces-de-mort-per-apoptosi-en-cellules-de-glioblastoma\/\" title=\"Aconsegueixen activar una prote\u00efna clau per completar el proc\u00e9s de mort per apoptosi en c\u00e8l\u00b7lules de glioblastoma\">Aconsegueixen activar una prote\u00efna clau per completar el proc\u00e9s de mort per apoptosi en c\u00e8l\u00b7lules de glioblastoma<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t24\/11\/2021\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/17903\" content=\"L'exercici evita el dany neuronal causat per la ter\u00e0pia contra el c\u00e0ncer de pulm\u00f3\" \/><meta itemprop=\"datePublished\" content=\"2021-06-03\" \/><meta itemprop=\"dateModified\" content=\"2021-06-03\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/06\/NP17-M-Simo_Eur-J-Neurology-Imatge-grup.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/06\/lexercici-evita-el-dany-neuronal-causat-per-la-terapia-contra-el-cancer-de-pulmo\/\" title=\"L'exercici evita el dany neuronal causat per la ter\u00e0pia contra el c\u00e0ncer de pulm\u00f3\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/06\/lexercici-evita-el-dany-neuronal-causat-per-la-terapia-contra-el-cancer-de-pulmo\/\" title=\"L'exercici evita el dany neuronal causat per la ter\u00e0pia contra el c\u00e0ncer de pulm\u00f3\">L&#8217;exercici evita el dany neuronal causat per la ter\u00e0pia contra el c\u00e0ncer de pulm\u00f3<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t03\/06\/2021\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/17288\" content=\"IDIBELL celebra el Kickoff Meeting sobre els Projectes d'Investigaci\u00f3 en Salut concedits per l'ISCIII\" \/><meta itemprop=\"datePublished\" content=\"2021-04-20\" \/><meta itemprop=\"dateModified\" content=\"2022-01-11\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/04\/MicrosoftTeams-image.jpg\" \/><meta itemprop=\"width\" content=\"1867\" \/><meta itemprop=\"height\" content=\"1161\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/04\/idibell-celebra-el-kickoff-meeting-sobre-els-projectes-dinvestigacio-en-salut-concedits-per-lisciii\/\" title=\"IDIBELL celebra el Kickoff Meeting sobre els Projectes d'Investigaci\u00f3 en Salut concedits per l'ISCIII\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/04\/idibell-celebra-el-kickoff-meeting-sobre-els-projectes-dinvestigacio-en-salut-concedits-per-lisciii\/\" title=\"IDIBELL celebra el Kickoff Meeting sobre els Projectes d'Investigaci\u00f3 en Salut concedits per l'ISCIII\">IDIBELL celebra el Kickoff Meeting sobre els Projectes d&#8217;Investigaci\u00f3 en Salut concedits per l&#8217;ISCIII<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t20\/04\/2021\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/17064\" content=\"Defineixen les caracter\u00edstiques cl\u00edniques de les complicacions cerebrals causades per immunoter\u00e0pies oncol\u00f2giques que en determinen l&#8217;evoluci\u00f3\" \/><meta itemprop=\"datePublished\" content=\"2021-03-30\" \/><meta itemprop=\"dateModified\" content=\"2021-03-30\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/03\/NO25-Bruna_JAMA-Imatge.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/03\/defineixen-les-caracteristiques-cliniques-de-les-complicacions-cerebrals-causades-per-immunoterapies-oncologiques-que-en-determinen-levolucio\/\" title=\"Defineixen les caracter\u00edstiques cl\u00edniques de les complicacions cerebrals causades per immunoter\u00e0pies oncol\u00f2giques que en determinen l&#8217;evoluci\u00f3\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/03\/defineixen-les-caracteristiques-cliniques-de-les-complicacions-cerebrals-causades-per-immunoterapies-oncologiques-que-en-determinen-levolucio\/\" title=\"Defineixen les caracter\u00edstiques cl\u00edniques de les complicacions cerebrals causades per immunoter\u00e0pies oncol\u00f2giques que en determinen l&#8217;evoluci\u00f3\">Defineixen les caracter\u00edstiques cl\u00edniques de les complicacions cerebrals causades per immunoter\u00e0pies oncol\u00f2giques que en determinen l&#8217;evoluci\u00f3<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t30\/03\/2021\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/7417\" content=\"Els supervivents de tumors cerebrals oligodendroglials corren el risc de desenvolupar deteriorament cognitiu a llarg termini\" \/><meta itemprop=\"datePublished\" content=\"2019-10-09\" \/><meta itemprop=\"dateModified\" content=\"2020-05-13\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/erigin\/\" \/><meta itemprop=\"name\" content=\"Idibell\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/05\/bruna.jpg\" \/><meta itemprop=\"width\" content=\"850\" \/><meta itemprop=\"height\" content=\"567\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2019\/10\/els-supervivents-de-tumors-cerebrals-oligodendroglials-corren-el-risc-de-desenvolupar-deteriorament-cognitiu-a-llarg-termini\/\" title=\"Els supervivents de tumors cerebrals oligodendroglials corren el risc de desenvolupar deteriorament cognitiu a llarg termini\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2019\/10\/els-supervivents-de-tumors-cerebrals-oligodendroglials-corren-el-risc-de-desenvolupar-deteriorament-cognitiu-a-llarg-termini\/\" title=\"Els supervivents de tumors cerebrals oligodendroglials corren el risc de desenvolupar deteriorament cognitiu a llarg termini\">Els supervivents de tumors cerebrals oligodendroglials corren el risc de desenvolupar deteriorament cognitiu a llarg termini<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/erigin\/\">Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t09\/10\/2019\t\t\t\t\t\t\t\n\t\t<!-- .pp-content-posts -->\n\n","protected":false},"excerpt":{"rendered":"<p>Neuro-oncologia Resum El grup de Neuro-oncologia se centra en l&#8217;estudi dels tractaments de tumors cerebrals i les complicacions neurol\u00f2giques relacionades amb el c\u00e0ncer i els tractaments contra el c\u00e0ncer. L&#8217;objectiu del grup \u00e9s crear i refor\u00e7ar una xarxa de recerca entre investigadors cl\u00ednics i precl\u00ednics tant dins com fora de la instituci\u00f3,\u00a0 per proporcionar noves [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":448,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-1916","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2024-12-29 06:53:02","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/1916","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=1916"}],"version-history":[{"count":10,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/1916\/revisions"}],"predecessor-version":[{"id":26847,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/1916\/revisions\/26847"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/448"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=1916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}